CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 149 filers reported holding CARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $418,000 | -98.6% | 29,335 | -97.9% | 0.03% | -96.7% |
| Q1 2021 | $30,504,000 | +250.5% | 1,405,124 | +144.3% | 1.03% | +168.1% |
| Q4 2020 | $8,702,000 | +106.3% | 575,224 | +73.5% | 0.38% | +25.6% |
| Q3 2020 | $4,219,000 | -15.8% | 331,524 | +13.1% | 0.30% | -23.6% |
| Q2 2020 | $5,012,000 | -33.6% | 293,124 | -48.7% | 0.40% | -29.8% |
| Q1 2020 | $7,553,000 | +2039.7% | 571,763 | +2510.8% | 0.57% | +896.5% |
| Q4 2019 | $353,000 | – | 21,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |